• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming - Cell

Mary Wilson

Well-known member
Published: December 01, 2022

DOI:https://doi.org/10.1016/j.cell.2022.11.030

Chien-Ting Wu [SUP]11, [/SUP]Peter V. Lidsky [SUP]11, [/SUP]Yinghong Xiao [SUP]11, [/SUP]Carlos Milla, Raul Andino, Peter K. Jackson [SUP]12[/SUP]
Show all authors

Highlights

  • SARS-CoV-2 binds ACE2 on multicilia in airway epithelia immediately upon infection

  • Depleting motile cilia inhibits viral entry by SARS-CoV-2 and other respiratory viruses

  • SARS-CoV-2 activates PAK kinases to rearrange airway microvilli driving viral exit

  • Omicron variants accelerate cilia-dependent entry through the airway mucin barrier
Summary

How SARS-CoV-2 penetrates the airway barrier of mucus and periciliary mucins to infect nasal epithelium remains unclear. Using primary nasal epithelial organoid cultures, we found the virus attaches to motile cilia via the ACE2 receptor. SARS-CoV-2 traverses the mucus layer, using motile cilia as tracks to access the cell body. Depleting cilia blocks infection for SARS-CoV-2 and other respiratory viruses. SARS-CoV-2 progeny attach to airway microvilli 24 hours post-infection and trigger formation of apically extended and highly branched microvilli that organize viral egress from the microvilli back into the mucus layer, supporting a model of virus dispersion throughout airway tissue via mucociliary transport. Phosphoproteomics and kinase inhibition reveal microvillar remodeling is regulated by PAK kinases. Importantly, Omicron variants bind with higher affinity to motile cilia and show accelerated viral entry. Our work suggests that motile cilia, microvilli, and mucociliary-dependent mucus flow are critical for efficient virus replication in nasal epithelia.

PDF Download 138MB

https://www.cell.com/cell/fulltext/S0092-8674(22)01505-7#articleInformation
 
Back
Top Bottom